Brown JE - Search Results

1

Serum lactate dehydrogenase is prognostic for survival in patients with bone metastases from breast cancer: a retrospective analysis in bisphosphonate-treated patients.

Brown JE, Cook RJ, Lipton A, Coleman RE. Brown JE, et al. Clin Cancer Res. 2012 Nov 15;18(22):6348-55. doi: 10.1158/1078-0432.CCR-12-1397. Epub 2012 Sep 4. Clin Cancer Res. 2012. PMID: 22952345

2

The present and future role of bisphosphonates in the management of patients with breast cancer.

Brown JE, Coleman RE. Brown JE, et al. Breast Cancer Res. 2002;4(1):24-9. doi: 10.1186/bcr413. Epub 2001 Nov 26. Breast Cancer Res. 2002. PMID: 11879556 Free PMC article. Review.

3

Chemotherapy, erythropoietin and bloodless surgery in a Jehovah's Witness.

Brown JE, Hatton MQ, Melchers R, Goldstraw P, Coleman RE. Brown JE, et al. Clin Oncol (R Coll Radiol). 2003 Oct;15(7):371-7. doi: 10.1016/s0936-6555(03)00193-6. Clin Oncol (R Coll Radiol). 2003. PMID: 14570083 No abstract available.

4

Bone resorption predicts for skeletal complications in metastatic bone disease.

Brown JE, Thomson CS, Ellis SP, Gutcher SA, Purohit OP, Coleman RE. Brown JE, et al. Br J Cancer. 2003 Dec 1;89(11):2031-7. doi: 10.1038/sj.bjc.6601437. Br J Cancer. 2003. PMID: 14647134 Free PMC article.

5

Assessment of the effects of breast cancer on bone and the response to therapy.

Brown JE, Coleman RE. Brown JE, et al. Breast. 2002 Oct;11(5):375-85. doi: 10.1054/brst.2002.0442. Breast. 2002. PMID: 14965699

6

The role of bisphosphonates in breast and prostate cancers.

Brown JE, Neville-Webbe H, Coleman RE. Brown JE, et al. Endocr Relat Cancer. 2004 Jun;11(2):207-24. doi: 10.1677/erc.0.0110207. Endocr Relat Cancer. 2004. PMID: 15163299 Review.

7

Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.

Brown JE, Cook RJ, Major P, Lipton A, Saad F, Smith M, Lee KA, Zheng M, Hei YJ, Coleman RE. Brown JE, et al. J Natl Cancer Inst. 2005 Jan 5;97(1):59-69. doi: 10.1093/jnci/dji002. J Natl Cancer Inst. 2005. PMID: 15632381

8

Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid.

Coleman RE, Major P, Lipton A, Brown JE, Lee KA, Smith M, Saad F, Zheng M, Hei YJ, Seaman J, Cook R. Coleman RE, et al. Among authors: brown je. J Clin Oncol. 2005 Aug 1;23(22):4925-35. doi: 10.1200/JCO.2005.06.091. Epub 2005 Jun 27. J Clin Oncol. 2005. PMID: 15983391

9

High incidence of late effects found in Hodgkin's lymphoma survivors, following recall for breast cancer screening.

Greenfield DM, Wright J, Brown JE, Hancock BW, Davies HA, O'Toole L, Eiser C, Coleman RE, Ross RJ. Greenfield DM, et al. Among authors: brown je. Br J Cancer. 2006 Feb 27;94(4):469-72. doi: 10.1038/sj.bjc.6602974. Br J Cancer. 2006. PMID: 16465193 Free PMC article.

10

Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours.

Santini D, Vincenzi B, Hannon RA, Brown JE, Dicuonzo G, Angeletti S, La Cesa A, Coleman RE, Tonini G, Budillon A, Caraglia M, Holen I. Santini D, et al. Among authors: brown je. Oncol Rep. 2006 May;15(5):1351-7. Oncol Rep. 2006. PMID: 16596210

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

764 results

Search Page

Filters